Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Preston T. Skersick"'
Autor:
Thamer A. Almangour, Preston T. Skersick, Amanda Corbett, Jo E. Rodgers, Patricia P. Chang, Claire E. Farel
Publikováno v:
AIDS Research and Therapy, Vol 20, Iss 1, Pp 1-8 (2023)
Abstract Background Antiretroviral therapy (ART) has led to a decline in human immunodeficiency virus (HIV)-related mortality, but comorbidities, including organ dysfunction, are increasingly the focus of care. Heart transplant (HT) is a very effecti
Externí odkaz:
https://doaj.org/article/5d03f8fc1046424f9edc830c0b9b1a31
Autor:
Preston T. Skersick, Darrian Proco, Preetika Sharma‐Huynh, Courtney A. Montepara, Jo E. Rodgers
Publikováno v:
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy. 42:837-848
Since initial publication of the PARADIGM-HF trial in 2014, sacubitril/valsartan has been investigated in various settings to establish optimal use, further expanding its indications in patients with heart failure (HF). Although numerous studies have
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::507f9eaed041fe14640aa9047a72d9e7
https://doi.org/10.1002/phar.2730
https://doi.org/10.1002/phar.2730
Autor:
Megan E. Cavagnini, Emily E. Best, Preston T. Skersick, Kelsey P. Truitt, Kaitlin L. Musick, Blake R. Mangum, Ian B. Hollis, Jo E. Rodgers
Publikováno v:
Journal of Pharmacy Practice. :089719002311597
Background: Sodium-glucose cotransporter 2 inhibitors (SGLT2i) have been shown to improve outcomes in patients with heart failure (HF) and are now included in guideline-directed medical therapy. Trials reporting the change in loop diuretic dose follo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::291d76059ea14063cdacff09fc4b4400
https://doi.org/10.1177/08971900231159739
https://doi.org/10.1177/08971900231159739